Imunon, Inc. (IMNN) has 33 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 15, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 15, 2026 filed Sept. 11, 2026 | Tardugno Michael H Executive Chairman of Board | $8,561 | 5,824 | +6% | No | |
|
|
||||||
| Sept. 15, 2026 filed Sept. 11, 2026 | Faller Douglas Vincent Chief Medical Officer | $6,190 | 4,211 | +11% | No | |
|
|
||||||
| Sept. 15, 2026 filed Sept. 11, 2026 | Lindborg Stacy President and CEO | $8,091 | 5,504 | +5% | No | |
|
|
||||||
| Sept. 1, 2026 filed Aug. 28, 2026 | Lindborg Stacy President and CEO | $10,915 | 6,822 | +7% | No | |
|
|
||||||
| Sept. 1, 2026 filed Aug. 28, 2026 | Tardugno Michael H Executive Chairman of Board | $11,794 | 7,371 | +9% | No | |
|
|
||||||
Showing the 5 most recent of 33 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free